TVTX - Travere Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TVTX is currently covered by 11 analysts with an average price target of $60.41. This is a potential upside of $3.48 (6.11%) from yesterday's end of day stock price of $56.93.

Travere Therapeutics's activity chart (see below) currently has 245 price targets and 213 ratings on display. The stock rating distribution of TVTX is 8.57% HOLD and 91.43% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90.03% with an average time for these price targets to be met of 457.97 days.

Highest price target for TVTX is $89, Lowest price target is $31, average price target is $60.41.

Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 24-Sep-2026.

Best performing analysts who are covering TVTX - Travere Therapeutics:

Michelle Gilson Joseph Pantginis Edward Nash Do Kim Vamil Divan Joseph Schwartz

Currently out of the existing stock ratings of TVTX, 3 are a HOLD (8.57%), 32 are a BUY (91.43%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Sep-2024

$89

$32.07 (56.33%)

$75

9 days ago
(24-Sep-2026)

10/12 (83.33%)

$28.38 (46.82%)

462

Buy Since 17-Apr-2023

$76

$19.07 (33.50%)

$75

11 days ago
(22-Sep-2026)

21/23 (91.3%)

$15.72 (26.08%)

311

Buy Since 01-Jul-2025

$67

$10.07 (17.69%)

$67

11 days ago
(22-Sep-2026)

9/10 (90%)

$6.72 (11.15%)

170

Buy Since 01-Oct-2025

$78

$18.56 (31.22%)

$68

1 months 22 days ago
(10-Aug-2026)

2/4 (50%)

$17.11 (28.10%)

39

Buy Since 23-Nov-2020

$78

$21.07 (37.01%)

$68

1 months 23 days ago
(10-Aug-2026)

10/12 (83.33%)

$17.11 (28.10%)

680

Show more analysts

Please expand the browser size to see the chart

What is TVTX (Travere Therapeutics) average time for price targets to be met?

On average it took 458 days for the stock forecasts to be reached, with an average price target met ratio of 90.03%.

Which analyst most recently updated their price target on TVTX (Travere Therapeutics)?

Vamil Divan

Which analyst has the most public recommendations on TVTX (Travere Therapeutics)?

Vamil Divan works at GUGGENHEIM and has 8 price targets and 7 ratings on TVTX

Which analyst is the currently most bullish on TVTX (Travere Therapeutics)?

Vamil Divan with the highest potential upside of $32.07

Which analyst is the currently most reserved on TVTX (Travere Therapeutics)?

Nicole Gabreski with the lowest potential downside of -$46.85
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?